Something biotechs tend to underestimate: the indication you pick dictates your commercial strategy. Most focus on the clinical profile of their drug, but in "payor-managed" indications, understanding the incentives of PBMs & other middlemen can make or break a launch (even if

Atlas Venture's 2024 Year In Review Here's our state of the industry talk for 2024. Interesting times, indeed. Covers innovation & impact, the investment climate, and a brief update on Atlas itself. lifescivc.com/2024/11/atlas-… #biotech Atlas Venture youtube.com/watch?v=szwRUE…

🎉 Exciting news! bit.bio is featured in the inaugural Sunday Times 100 Tech as a Biotech One to Watch! Honoured to be recognised for advancing access to cells for human health. 🙌 #Biotech #TechInnovation #SundayTimesTech100

The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice: Cell Reports cell.com/cell-reports/f…

🚨 NEW ioCELLS ALERT! 🚨 Introducing ioTracker Cells for added visualisation functionality to opti-ox powered hiPSC-derived cells. First up: GFP ioMicroglia, for easy tracking & isolation in complex cultures. Learn more: hubs.ly/Q0342mrD0 #Neurodegeneration #ioCells

Join us at #SLAS2025 today at 8:30 AM PST for our exhibitor tutorial showcasing real-world applications of #ioCells in #drugdiscovery. Not at SLAS? Access our posters featuring the NEW GFP ioMicroglia co-cultured with ioGlutamatergic Neurons: hubs.ly/Q034jPpx0

Kept seeing comments saying the video looks like a commercial, so i made it one "It's not luck."

#MFFL

We are very grateful to the United States for all the support. I’m thankful to President Trump, Congress for their bipartisan support, and American people. Ukrainians have always appreciated this support, especially during these three years of full-scale invasion.

In Science, researchers detail a nanoscale-resolution reconstruction of a millimeter-scale fragment of human cerebral cortex, giving an unprecedented view into the structural organization of brain tissue at the supracellular, cellular, and subcellular levels. Learn more during

It has taken decades to get to this point, but stem cells for Parkinson's disease showing promise in 2 clinical trials nature.com/articles/d4158… nature.com/articles/s4158… nature.com/articles/s4158…

Here is a much needed dose of optimism by David R. Liu about the huge potential of Gene Editing & how it is changing our lives. The remarkable advancement in the Gene editing field & specifically in Base Editing - $BEAM & Prime Editing $PRME is providing hope to so many patients!

Atlas Venture 2025 Year In Review lifescivc.com/2025/11/atlas-… Been a tough year to pin down as we went from bearish spring to bullish yea end… Listening at 1.25x+ speed is definitely recommended, and moves through the nearly 50-minute presentation slightly faster.

I’ve signed 100% of compassionate use requests that have come to my desk.

50 wins in a gap year ☘️

Basketball Capital of the World….Storrs Connecticut. 🐺💙🏀

🚨 Major boost for US biotech: The White House backed U.S. FDA proposal for an **optional risk-based Expedited IND pathway** — slashing Phase 1 timelines to first-in-human trials using validated preclinical data. Reduces duplicative requirements that drive longer/higher-burden US

Fuck Everything, We're Doing Five Agonists